Skip to content

Clinical trials

Completed Hepatitis C, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Status: Completed Country / region: United States Clear all

208 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20022
20038
200411
20057
20066
200717
200818
20099
201010
201130
201224
201313
20147
20157
20169
201711
20182
20191
20203
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed208

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche31
Gilead Sciences23
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)16
Bristol-Myers Squibb10
Boehringer Ingelheim9
AbbVie7
University of North Carolina, Chapel Hill6
Vertex Pharmaceuticals Incorporated6
GlaxoSmithKline5
Merck Sharp & Dohme LLC5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic208
Hepatitis C91
Liver Diseases18
Hepatitis17
Fibrosis12
Hepatitis, Chronic10
Virus Diseases7
Acquired Immunodeficiency Syndrome6
Digestive System Diseases5
HIV Infections5

Trials

Showing 1 to 25 of 208. Each trial links to its page on Pharma Observatory.

108 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.